A randomized, double-blind, placebo-controlled, three-way crossover, Phase 1 trial to quantitatively assess any effects of IV difelikefalin (CR845) on respiratory drive after bolus infusion in healthy volunteers

Trial Profile

A randomized, double-blind, placebo-controlled, three-way crossover, Phase 1 trial to quantitatively assess any effects of IV difelikefalin (CR845) on respiratory drive after bolus infusion in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2017

At a glance

  • Drugs Difelikefalin (Primary)
  • Indications Pain; Pruritus
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Apr 2017 Data will be presented as part of the Journal Anesthesiology Symposium at the American Society of Anesthesiology (ASA) Annual Meeting, as reported in a Cara Therapeutics media release.
    • 24 Apr 2017 Summary results published in the Cara Therapeutics Media Release
    • 16 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top